Speaker Profile

Ph.D., CEO, Cofactor Genomics

Dr. Jarret Glasscock received his Phd in Molecular Genetics/Computational Biology from Washington University while working on The Human Genome project under Warren Gish. Prior to that, he studied at University of Arizona where he received a BS in Molecular Biology with a Computer Science emphasis. Jarret led the Computational Biology group at The Genome Institute and was part of the Technology Development team prior to co-founding Cofactor Genomics. Today Jarret is the CEO of Cofactor Genomics, a company focused on developing RNA-based technologies that enable a new generation of diagnostics to make personalized medicine a reality. Jarret has been covered by Genetic Engineering News (GEN), Tech Crunch, and Wired Magazine. He is a member of the Personalized Medicine Coalition, International Society for Computational Biology, and is a Y Combinator Alum.

Presentation Title and Company Description

AI and Data Science Showcase: RNA, Machine Learning, and Immune Oncology
Cofactor Genomics is a leader in developing tools to interrogate RNA. Cofactor’s CAP-CLIA RNA-seq based tumor profiling diagnostics leverage molecular technologies and machine learning to characterize both the tumor and tumor micro-environment.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.